Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.

Feugeas, O; Guriec, N; Babin-Boilletot, A; Marcellin, L; Simon, P; Babin, S; Thyss, A; Hofman, P; Terrier, P; Kalifa, C; Brunat-Mentigny, M; Patricot, L M; Oberling, F

Feugeas, O; Guriec, N; Babin-Boilletot, A; Marcellin, L; Simon, P; Babin, S; Thyss, A; Hofman, P; Terrier, P; Kalifa, C; Brunat-Mentigny, M; Patricot, L M; Oberling, F.

Affiliation

Feugeas O; Department of Oncohematology, Hôpital de Hautepierre, Strasbourg, France.

J Clin Oncol ; 14(2): 467-72, 1996 Feb.

Article in En | MEDLINE | ID: mdl-8636759

Subject(s)

Bone Neoplasms/genetics; Bone Neoplasms/mortality; Genes, Retinoblastoma; Osteosarcoma/genetics; Osteosarcoma/mortality; Adolescent; Adult; Base Sequence; Child; Heterozygote; Humans; Molecular Sequence Data; Prognosis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / Genes, Retinoblastoma Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: J Clin Oncol Year: 1996 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links